Victory Capital Management
RCKT icon

Victory Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Victory Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.9K Buy
11,968
+410
+4% +$1.36K ﹤0.01% 2406
2026
Q1 		$41.4K Buy
11,558
+89
+0.8% +$354 ﹤0.01% 2328
2025
Q4 		$40.3K Buy
11,469
+79
+0.7% +$270 ﹤0.01% 2350
2025
Q3 		$37.1K Sell
11,390
-507
-4% -$1.6K ﹤0.01% 2367
2025
Q2 		$29.1K Sell
11,897
-32
-0.3% -$162 ﹤0.01% 2419
2025
Q1 		$79.6K Buy
11,929
+1,658
+16% +$16.4K ﹤0.01% 2334
2024
Q4 		$129K Sell
10,271
-366
-3% -$5.51K ﹤0.01% 2305
2024
Q3 		$196K Sell
10,637
-171
-2% -$3.5K ﹤0.01% 2230
2024
Q2 		$233K Sell
10,808
-37,210
-77% -$855K ﹤0.01% 2163
2024
Q1 		$1.29M Buy
48,018
+2,510
+6% +$71.3K ﹤0.01% 1615
2023
Q4 		$1.36M Buy
45,508
+6,298
+16% +$139K ﹤0.01% 1576
2023
Q3 		$803K Sell
39,210
-6,850
-15% -$125K ﹤0.01% 1762
2023
Q2 		$915K Buy
46,060
+6,410
+16% +$130K ﹤0.01% 1718
2023
Q1 		$679K Buy
+39,650
New +$776K ﹤0.01% 1880
2021
Q4 		– Sell
-9,066
Closed -$271K – 2833
2021
Q3 		$271K Sell
9,066
-324
-3% -$11.8K ﹤0.01% 2418
2021
Q2 		$416K Buy
9,390
+457
+5% +$19.8K ﹤0.01% 2294
2021
Q1 		$396K Buy
8,933
+883
+11% +$48.5K ﹤0.01% 2305
2020
Q4 		$441K Buy
+8,050
New +$293K ﹤0.01% 2144
2020
Q2 		– Sell
-8,238
Closed -$115K – 3107
2020
Q1 		$115K Sell
8,238
-2,584
-24% -$51.2K ﹤0.01% 2288
2019
Q4 		$246K Buy
10,822
+2,944
+37% +$49.2K ﹤0.01% 2260
2019
Q3 		$92K Buy
+7,878
New +$97.8K ﹤0.01% 2464

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Victory Capital Management's RCKT Position: Q2 2026 in Review

Victory Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 3.5% in Q2 2026, buying an estimated $1.36K and bringing the position to 11,968 shares worth $40.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

Victory Capital Management first reported a position in RCKT in Q3 2019 and has held it in 21 quarters since. The position peaked at $1.36M in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Victory Capital Management held 11,968 shares of Rocket Pharmaceuticals worth $40.9K as of Q2 2026.
  • Victory Capital Management bought 410 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2406 holding.
  • Victory Capital Management first reported a position in Rocket Pharmaceuticals in Q3 2019 and has held it in 21 quarters since.
  • Victory Capital Management's Rocket Pharmaceuticals position peaked at $1.36M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.